f 1394 has been researched along with Disease Models, Animal in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bander, I; Blachford, C; Davis, M; Dehn, S; Feig, JE; Fisher, EA; Kusunoki, J; Mayne, J; Miller, C; Rong, JX; Rudel, LL; Tabas, I; Taubman, MB; Thorp, E; Wilson, M | 1 |
Aragane, K; Chiwata, T; Fujinami, K; Kano, K; Kitamine, T; Kojima, K; Kozono, H; Kusunoki, J; Sekine, Y | 1 |
2 other study(ies) available for f 1394 and Disease Models, Animal
Article | Year |
---|---|
ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.
Topics: Acetyl-CoA C-Acyltransferase; Animals; Aorta; Aortic Diseases; Apolipoproteins E; Apoptosis; Atherosclerosis; Cholesterol; Cyclohexanes; Diet, Atherogenic; Dioxanes; Disease Models, Animal; Disease Progression; Enzyme Inhibitors; Foam Cells; Male; Mice; Mice, Knockout; Necrosis; Plaque, Atherosclerotic; Thromboplastin | 2013 |
Postprandial hyperlipidemia in streptozotocin-induced diabetic rats is due to abnormal increase in intestinal acyl coenzyme A:cholesterol acyltransferase activity.
Topics: Animals; Cholesterol; Cyclohexanes; Diabetes Mellitus, Experimental; Dietary Fats; Dioxanes; Disease Models, Animal; Eating; Enzyme Inhibitors; Hyperlipidemias; Intestine, Small; Lymphatic System; Male; Rats; Rats, Sprague-Dawley; Risk Factors; Sterol O-Acyltransferase; Triglycerides | 2000 |